Latest News and Articles about Sonnet BioTherapeutics

Hyperliquid (HYPE) Soars as Sonnet Bets $888M on Bold Crypto Treasury Shift A stunning move in the crypto space has jaws dropping as Sonnet BioTherapeutics, a US-based publicly traded company, abandons its biotech roots to rebrand as Hyperliquid Strategies, pouring a massive $888 million into the Hyperliquid (HYPE) ecosystem. Backed by crypto giants like Paradigm […]